DOI:
10.1055/s-00000075
Seminars in Respiratory and Critical Care Medicine
LinksClose Window
References
Spyropoulos AC, Ashton V, Chen YW, Wu B, Peterson ED.
Rivaroxaban versus warfarin treatment among morbidly obese patients with venous thromboembolism: comparative effectiveness, safety, and costs.
Thromb Res 2019;
182: 159-166
We do not assume any responsibility for the contents of the web pages of other providers.